Hussman Strategic Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.79M | Buy |
+52,500
| New | +$2.79M | 0.64% | 58 |
|
2024
Q4 | – | Sell |
-16,800
| Closed | -$1.14M | – | 263 |
|
2024
Q3 | $1.14M | Sell |
16,800
-25,200
| -60% | -$1.72M | 0.28% | 151 |
|
2024
Q2 | $1.77M | Hold |
42,000
| – | – | 0.49% | 91 |
|
2024
Q1 | $2.9M | Buy |
42,000
+10,500
| +33% | +$725K | 0.67% | 56 |
|
2023
Q4 | $2.33M | Buy |
31,500
+25,200
| +400% | +$1.86M | 0.53% | 69 |
|
2023
Q3 | $430K | Buy |
+6,300
| New | +$430K | 0.08% | 248 |
|
2022
Q2 | – | Sell |
-7,800
| Closed | -$545K | – | 340 |
|
2022
Q1 | $545K | Hold |
7,800
| – | – | 0.11% | 251 |
|
2021
Q4 | $607K | Sell |
7,800
-1,500
| -16% | -$117K | 0.13% | 223 |
|
2021
Q3 | $888K | Sell |
9,300
-3,100
| -25% | -$296K | 0.2% | 170 |
|
2021
Q2 | $1.54M | Buy |
12,400
+8,800
| +244% | +$1.09M | 0.32% | 121 |
|
2021
Q1 | $474K | Buy |
+3,600
| New | +$474K | 0.1% | 263 |
|
2020
Q3 | – | Sell |
-10,000
| Closed | -$869K | – | 274 |
|
2020
Q2 | $869K | Sell |
10,000
-15,000
| -60% | -$1.3M | 0.22% | 173 |
|
2020
Q1 | $1.45M | Buy |
25,000
+15,000
| +150% | +$870K | 0.39% | 98 |
|
2019
Q4 | $925K | Buy |
+10,000
| New | +$925K | 0.29% | 126 |
|
2019
Q2 | – | Sell |
-10,000
| Closed | -$866K | – | 204 |
|
2019
Q1 | $866K | Sell |
10,000
-5,000
| -33% | -$433K | 0.21% | 163 |
|
2018
Q4 | $946K | Sell |
15,000
-5,000
| -25% | -$315K | 0.23% | 163 |
|
2018
Q3 | $1.58M | Sell |
20,000
-5,000
| -20% | -$395K | 0.46% | 98 |
|
2018
Q2 | $1.5M | Sell |
25,000
-50,000
| -67% | -$2.99M | 0.4% | 111 |
|
2018
Q1 | $3.03M | Buy |
+75,000
| New | +$3.03M | 0.84% | 46 |
|